Dr Clare Craig explains why the FDA should NOT have granted approval for roll-out

1/ Dr Clare Craig explains why the FDA should NOT have granted approval for roll-out in the 6 month to 4 yr old children cohort

This trial should have been deemed null and void. The regulators are failing to do their job.

Share widely & follow

@hartgroup_org for updates

2/ Part 2 It should be noted, the FDA voted unanimously to approve the drug for this age group. Given the problems outlined, this is unbelievable. Follow

@hartgroup_org for further updates. Please share widely

@MaajidNawaz

@DrAseemMalhotra

@vacsafety

@EthicalSkeptic

Leave a Reply